Report Overview
Investigational New Drug CDMO refers to a Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of investigational new drugs (INDs). INDs are drugs that are being tested for their safety and efficacy in clinical trials before they receive regulatory approval for general use. An Investigational New Drug CDMO provides services including formulation development, process optimization, scale-up, and manufacturing of INDs to support the drug development process. These organizations play a crucial role in helping pharmaceutical companies bring new drugs from the research phase through to clinical trials.
The global Investigational New Drug CDMO market size was estimated at USD 4855 million in 2023 and is projected to reach USD 8557.28 million by 2032, exhibiting a CAGR of 6.50% during the forecast period.
North America Investigational New Drug CDMO market size was estimated at USD 1409.97 million in 2023, at a CAGR of 5.57% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Investigational New Drug CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Investigational New Drug CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Investigational New Drug CDMO market in any manner.
Global Investigational New Drug CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Inc.
Lonza
Recipharm AB
Siegfried Holding AG
Patheon Inc.
Covance
IQVIA Holdings Inc.
Cambrex Corporation
Charles River Laboratories International
Inc.
Syneous Health
Market Segmentation (by Type)
Small Molecule
Large Molecule
Market Segmentation (by Application)
Pharmaceutical Companies
Biotech Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Investigational New Drug CDMO Market
Overview of the regional outlook of the Investigational New Drug CDMO Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Investigational New Drug CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Investigational New Drug CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Investigational New Drug CDMO
1.2 Key Market Segments
1.2.1 Investigational New Drug CDMO Segment by Type
1.2.2 Investigational New Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Investigational New Drug CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Investigational New Drug CDMO Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Investigational New Drug CDMO Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Investigational New Drug CDMO Market Competitive Landscape
3.1 Global Investigational New Drug CDMO Sales by Manufacturers (2019-2025)
3.2 Global Investigational New Drug CDMO Revenue Market Share by Manufacturers (2019-2025)
3.3 Investigational New Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Investigational New Drug CDMO Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Investigational New Drug CDMO Sales Sites, Area Served, Product Type
3.6 Investigational New Drug CDMO Market Competitive Situation and Trends
3.6.1 Investigational New Drug CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Investigational New Drug CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Investigational New Drug CDMO Industry Chain Analysis
4.1 Investigational New Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Investigational New Drug CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Investigational New Drug CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Investigational New Drug CDMO Sales Market Share by Type (2019-2025)
6.3 Global Investigational New Drug CDMO Market Size Market Share by Type (2019-2025)
6.4 Global Investigational New Drug CDMO Price by Type (2019-2025)
7 Investigational New Drug CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Investigational New Drug CDMO Market Sales by Application (2019-2025)
7.3 Global Investigational New Drug CDMO Market Size (M USD) by Application (2019-2025)
7.4 Global Investigational New Drug CDMO Sales Growth Rate by Application (2019-2025)
8 Investigational New Drug CDMO Market Consumption by Region
8.1 Global Investigational New Drug CDMO Sales by Region
8.1.1 Global Investigational New Drug CDMO Sales by Region
8.1.2 Global Investigational New Drug CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Investigational New Drug CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Investigational New Drug CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Investigational New Drug CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Investigational New Drug CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Investigational New Drug CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Investigational New Drug CDMO Market Production by Region
9.1 Global Production of Investigational New Drug CDMO by Region (2019-2025)
9.2 Global Investigational New Drug CDMO Revenue Market Share by Region (2019-2025)
9.3 Global Investigational New Drug CDMO Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Investigational New Drug CDMO Production
9.4.1 North America Investigational New Drug CDMO Production Growth Rate (2019-2025)
9.4.2 North America Investigational New Drug CDMO Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Investigational New Drug CDMO Production
9.5.1 Europe Investigational New Drug CDMO Production Growth Rate (2019-2025)
9.5.2 Europe Investigational New Drug CDMO Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Investigational New Drug CDMO Production (2019-2025)
9.6.1 Japan Investigational New Drug CDMO Production Growth Rate (2019-2025)
9.6.2 Japan Investigational New Drug CDMO Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Investigational New Drug CDMO Production (2019-2025)
9.7.1 China Investigational New Drug CDMO Production Growth Rate (2019-2025)
9.7.2 China Investigational New Drug CDMO Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Catalent
10.1.1 Catalent Investigational New Drug CDMO Basic Information
10.1.2 Catalent Investigational New Drug CDMO Product Overview
10.1.3 Catalent Investigational New Drug CDMO Product Market Performance
10.1.4 Catalent Business Overview
10.1.5 Catalent Investigational New Drug CDMO SWOT Analysis
10.1.6 Catalent Recent Developments
10.2 Inc.
10.2.1 Inc. Investigational New Drug CDMO Basic Information
10.2.2 Inc. Investigational New Drug CDMO Product Overview
10.2.3 Inc. Investigational New Drug CDMO Product Market Performance
10.2.4 Inc. Business Overview
10.2.5 Inc. Investigational New Drug CDMO SWOT Analysis
10.2.6 Inc. Recent Developments
10.3 Lonza
10.3.1 Lonza Investigational New Drug CDMO Basic Information
10.3.2 Lonza Investigational New Drug CDMO Product Overview
10.3.3 Lonza Investigational New Drug CDMO Product Market Performance
10.3.4 Lonza Investigational New Drug CDMO SWOT Analysis
10.3.5 Lonza Business Overview
10.3.6 Lonza Recent Developments
10.4 Recipharm AB
10.4.1 Recipharm AB Investigational New Drug CDMO Basic Information
10.4.2 Recipharm AB Investigational New Drug CDMO Product Overview
10.4.3 Recipharm AB Investigational New Drug CDMO Product Market Performance
10.4.4 Recipharm AB Business Overview
10.4.5 Recipharm AB Recent Developments
10.5 Siegfried Holding AG
10.5.1 Siegfried Holding AG Investigational New Drug CDMO Basic Information
10.5.2 Siegfried Holding AG Investigational New Drug CDMO Product Overview
10.5.3 Siegfried Holding AG Investigational New Drug CDMO Product Market Performance
10.5.4 Siegfried Holding AG Business Overview
10.5.5 Siegfried Holding AG Recent Developments
10.6 Patheon Inc.
10.6.1 Patheon Inc. Investigational New Drug CDMO Basic Information
10.6.2 Patheon Inc. Investigational New Drug CDMO Product Overview
10.6.3 Patheon Inc. Investigational New Drug CDMO Product Market Performance
10.6.4 Patheon Inc. Business Overview
10.6.5 Patheon Inc. Recent Developments
10.7 Covance
10.7.1 Covance Investigational New Drug CDMO Basic Information
10.7.2 Covance Investigational New Drug CDMO Product Overview
10.7.3 Covance Investigational New Drug CDMO Product Market Performance
10.7.4 Covance Business Overview
10.7.5 Covance Recent Developments
10.8 IQVIA Holdings Inc.
10.8.1 IQVIA Holdings Inc. Investigational New Drug CDMO Basic Information
10.8.2 IQVIA Holdings Inc. Investigational New Drug CDMO Product Overview
10.8.3 IQVIA Holdings Inc. Investigational New Drug CDMO Product Market Performance
10.8.4 IQVIA Holdings Inc. Business Overview
10.8.5 IQVIA Holdings Inc. Recent Developments
10.9 Cambrex Corporation
10.9.1 Cambrex Corporation Investigational New Drug CDMO Basic Information
10.9.2 Cambrex Corporation Investigational New Drug CDMO Product Overview
10.9.3 Cambrex Corporation Investigational New Drug CDMO Product Market Performance
10.9.4 Cambrex Corporation Business Overview
10.9.5 Cambrex Corporation Recent Developments
10.10 Charles River Laboratories International
10.10.1 Charles River Laboratories International Investigational New Drug CDMO Basic Information
10.10.2 Charles River Laboratories International Investigational New Drug CDMO Product Overview
10.10.3 Charles River Laboratories International Investigational New Drug CDMO Product Market Performance
10.10.4 Charles River Laboratories International Business Overview
10.10.5 Charles River Laboratories International Recent Developments
10.11 Inc.
10.11.1 Inc. Investigational New Drug CDMO Basic Information
10.11.2 Inc. Investigational New Drug CDMO Product Overview
10.11.3 Inc. Investigational New Drug CDMO Product Market Performance
10.11.4 Inc. Business Overview
10.11.5 Inc. Recent Developments
10.12 Syneous Health
10.12.1 Syneous Health Investigational New Drug CDMO Basic Information
10.12.2 Syneous Health Investigational New Drug CDMO Product Overview
10.12.3 Syneous Health Investigational New Drug CDMO Product Market Performance
10.12.4 Syneous Health Business Overview
10.12.5 Syneous Health Recent Developments
11 Investigational New Drug CDMO Market Forecast by Region
11.1 Global Investigational New Drug CDMO Market Size Forecast
11.2 Global Investigational New Drug CDMO Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Investigational New Drug CDMO Market Size Forecast by Country
11.2.3 Asia Pacific Investigational New Drug CDMO Market Size Forecast by Region
11.2.4 South America Investigational New Drug CDMO Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Investigational New Drug CDMO by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Investigational New Drug CDMO Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Investigational New Drug CDMO by Type (2025-2032)
12.1.2 Global Investigational New Drug CDMO Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Investigational New Drug CDMO by Type (2025-2032)
12.2 Global Investigational New Drug CDMO Market Forecast by Application (2025-2032)
12.2.1 Global Investigational New Drug CDMO Sales (K Units) Forecast by Application
12.2.2 Global Investigational New Drug CDMO Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Investigational New Drug CDMO Market Size Comparison by Region (M USD)
Table 5. Global Investigational New Drug CDMO Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Investigational New Drug CDMO Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Investigational New Drug CDMO Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Investigational New Drug CDMO Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug CDMO as of 2022)
Table 10. Global Market Investigational New Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Investigational New Drug CDMO Sales Sites and Area Served
Table 12. Manufacturers Investigational New Drug CDMO Product Type
Table 13. Global Investigational New Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Investigational New Drug CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Investigational New Drug CDMO Market Challenges
Table 22. Global Investigational New Drug CDMO Sales by Type (K Units)
Table 23. Global Investigational New Drug CDMO Market Size by Type (M USD)
Table 24. Global Investigational New Drug CDMO Sales (K Units) by Type (2019-2025)
Table 25. Global Investigational New Drug CDMO Sales Market Share by Type (2019-2025)
Table 26. Global Investigational New Drug CDMO Market Size (M USD) by Type (2019-2025)
Table 27. Global Investigational New Drug CDMO Market Size Share by Type (2019-2025)
Table 28. Global Investigational New Drug CDMO Price (USD/Unit) by Type (2019-2025)
Table 29. Global Investigational New Drug CDMO Sales (K Units) by Application
Table 30. Global Investigational New Drug CDMO Market Size by Application
Table 31. Global Investigational New Drug CDMO Sales by Application (2019-2025) & (K Units)
Table 32. Global Investigational New Drug CDMO Sales Market Share by Application (2019-2025)
Table 33. Global Investigational New Drug CDMO Sales by Application (2019-2025) & (M USD)
Table 34. Global Investigational New Drug CDMO Market Share by Application (2019-2025)
Table 35. Global Investigational New Drug CDMO Sales Growth Rate by Application (2019-2025)
Table 36. Global Investigational New Drug CDMO Sales by Region (2019-2025) & (K Units)
Table 37. Global Investigational New Drug CDMO Sales Market Share by Region (2019-2025)
Table 38. North America Investigational New Drug CDMO Sales by Country (2019-2025) & (K Units)
Table 39. Europe Investigational New Drug CDMO Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Investigational New Drug CDMO Sales by Region (2019-2025) & (K Units)
Table 41. South America Investigational New Drug CDMO Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Investigational New Drug CDMO Sales by Region (2019-2025) & (K Units)
Table 43. Global Investigational New Drug CDMO Production (K Units) by Region (2019-2025)
Table 44. Global Investigational New Drug CDMO Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Investigational New Drug CDMO Revenue Market Share by Region (2019-2025)
Table 46. Global Investigational New Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Investigational New Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Investigational New Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Investigational New Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Investigational New Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Catalent Investigational New Drug CDMO Basic Information
Table 52. Catalent Investigational New Drug CDMO Product Overview
Table 53. Catalent Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Catalent Business Overview
Table 55. Catalent Investigational New Drug CDMO SWOT Analysis
Table 56. Catalent Recent Developments
Table 57. Inc. Investigational New Drug CDMO Basic Information
Table 58. Inc. Investigational New Drug CDMO Product Overview
Table 59. Inc. Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Inc. Business Overview
Table 61. Inc. Investigational New Drug CDMO SWOT Analysis
Table 62. Inc. Recent Developments
Table 63. Lonza Investigational New Drug CDMO Basic Information
Table 64. Lonza Investigational New Drug CDMO Product Overview
Table 65. Lonza Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Lonza Investigational New Drug CDMO SWOT Analysis
Table 67. Lonza Business Overview
Table 68. Lonza Recent Developments
Table 69. Recipharm AB Investigational New Drug CDMO Basic Information
Table 70. Recipharm AB Investigational New Drug CDMO Product Overview
Table 71. Recipharm AB Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Recipharm AB Business Overview
Table 73. Recipharm AB Recent Developments
Table 74. Siegfried Holding AG Investigational New Drug CDMO Basic Information
Table 75. Siegfried Holding AG Investigational New Drug CDMO Product Overview
Table 76. Siegfried Holding AG Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Siegfried Holding AG Business Overview
Table 78. Siegfried Holding AG Recent Developments
Table 79. Patheon Inc. Investigational New Drug CDMO Basic Information
Table 80. Patheon Inc. Investigational New Drug CDMO Product Overview
Table 81. Patheon Inc. Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Patheon Inc. Business Overview
Table 83. Patheon Inc. Recent Developments
Table 84. Covance Investigational New Drug CDMO Basic Information
Table 85. Covance Investigational New Drug CDMO Product Overview
Table 86. Covance Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Covance Business Overview
Table 88. Covance Recent Developments
Table 89. IQVIA Holdings Inc. Investigational New Drug CDMO Basic Information
Table 90. IQVIA Holdings Inc. Investigational New Drug CDMO Product Overview
Table 91. IQVIA Holdings Inc. Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. IQVIA Holdings Inc. Business Overview
Table 93. IQVIA Holdings Inc. Recent Developments
Table 94. Cambrex Corporation Investigational New Drug CDMO Basic Information
Table 95. Cambrex Corporation Investigational New Drug CDMO Product Overview
Table 96. Cambrex Corporation Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Cambrex Corporation Business Overview
Table 98. Cambrex Corporation Recent Developments
Table 99. Charles River Laboratories International Investigational New Drug CDMO Basic Information
Table 100. Charles River Laboratories International Investigational New Drug CDMO Product Overview
Table 101. Charles River Laboratories International Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Charles River Laboratories International Business Overview
Table 103. Charles River Laboratories International Recent Developments
Table 104. Inc. Investigational New Drug CDMO Basic Information
Table 105. Inc. Investigational New Drug CDMO Product Overview
Table 106. Inc. Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Inc. Business Overview
Table 108. Inc. Recent Developments
Table 109. Syneous Health Investigational New Drug CDMO Basic Information
Table 110. Syneous Health Investigational New Drug CDMO Product Overview
Table 111. Syneous Health Investigational New Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Syneous Health Business Overview
Table 113. Syneous Health Recent Developments
Table 114. Global Investigational New Drug CDMO Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Investigational New Drug CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Investigational New Drug CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Investigational New Drug CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Investigational New Drug CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Investigational New Drug CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Investigational New Drug CDMO Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Investigational New Drug CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Investigational New Drug CDMO Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Investigational New Drug CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Investigational New Drug CDMO Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Investigational New Drug CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Investigational New Drug CDMO Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Investigational New Drug CDMO Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Investigational New Drug CDMO Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Investigational New Drug CDMO Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Investigational New Drug CDMO Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Investigational New Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Investigational New Drug CDMO Market Size (M USD), 2019-2032
Figure 5. Global Investigational New Drug CDMO Market Size (M USD) (2019-2032)
Figure 6. Global Investigational New Drug CDMO Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Investigational New Drug CDMO Market Size by Country (M USD)
Figure 11. Investigational New Drug CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Investigational New Drug CDMO Revenue Share by Manufacturers in 2023
Figure 13. Investigational New Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Investigational New Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Investigational New Drug CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Investigational New Drug CDMO Market Share by Type
Figure 18. Sales Market Share of Investigational New Drug CDMO by Type (2019-2025)
Figure 19. Sales Market Share of Investigational New Drug CDMO by Type in 2023
Figure 20. Market Size Share of Investigational New Drug CDMO by Type (2019-2025)
Figure 21. Market Size Market Share of Investigational New Drug CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Investigational New Drug CDMO Market Share by Application
Figure 24. Global Investigational New Drug CDMO Sales Market Share by Application (2019-2025)
Figure 25. Global Investigational New Drug CDMO Sales Market Share by Application in 2023
Figure 26. Global Investigational New Drug CDMO Market Share by Application (2019-2025)
Figure 27. Global Investigational New Drug CDMO Market Share by Application in 2023
Figure 28. Global Investigational New Drug CDMO Sales Growth Rate by Application (2019-2025)
Figure 29. Global Investigational New Drug CDMO Sales Market Share by Region (2019-2025)
Figure 30. North America Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Investigational New Drug CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Investigational New Drug CDMO Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Investigational New Drug CDMO Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Investigational New Drug CDMO Sales Market Share by Country in 2023
Figure 37. Germany Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Investigational New Drug CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Investigational New Drug CDMO Sales Market Share by Region in 2023
Figure 44. China Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Investigational New Drug CDMO Sales and Growth Rate (K Units)
Figure 50. South America Investigational New Drug CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Investigational New Drug CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Investigational New Drug CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Investigational New Drug CDMO Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Investigational New Drug CDMO Production Market Share by Region (2019-2025)
Figure 62. North America Investigational New Drug CDMO Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Investigational New Drug CDMO Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Investigational New Drug CDMO Production (K Units) Growth Rate (2019-2025)
Figure 65. China Investigational New Drug CDMO Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Investigational New Drug CDMO Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Investigational New Drug CDMO Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Investigational New Drug CDMO Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Investigational New Drug CDMO Market Share Forecast by Type (2025-2032)
Figure 70. Global Investigational New Drug CDMO Sales Forecast by Application (2025-2032)
Figure 71. Global Investigational New Drug CDMO Market Share Forecast by Application (2025-2032)
